Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signaling.
Breast Cancer Res. 2022 May 14;24(1):33. doi: 10.1186/s13058-022-01526-y.
Breast Cancer Res. 2022.
PMID: 35568869
Free PMC article.
Beta 2 Adrenergic Receptor Antagonist Propranolol and Opioidergic Receptor Antagonist Naltrexone Produce Synergistic Effects on Breast Cancer Growth Prevention by Acting on Cancer Cells and Immune Environment in a Preclinical Model of Breast Cancer.
Murugan S, Rousseau B, Sarkar DK.
Murugan S, et al.
Cancers (Basel). 2021 Sep 28;13(19):4858. doi: 10.3390/cancers13194858.
Cancers (Basel). 2021.
PMID: 34638341
Free PMC article.
Item in Clipboard
Cite
Cite